Development of health-related quality of life and symptoms in patients with advanced cancer in Greenland

M Augustussen, M L Pedersen, L Hounsgaard, H Timm, P Sjøgren

    1 Citation (Scopus)


    A prospective national cohort study assessed the development of health-related quality of life (HRQoL) and symptoms in adult patients undergoing treatment and care for advanced cancer in Greenland. HRQol was examined by EORTC QLQ-C30 version 3.0 questionnaire monthly for 4 months. Changes over time and between-group comparisons were examined. Of 58 patients included in the study, 47% completed the questionnaire four times. Functioning was generally high, and improved social functioning was observed after 1 and 2 months. The highest symptom score was for fatigue followed by pain and nausea/vomiting. A high score for financial problems remained unchanged during the entire period. Patients with higher income had reduced pain intensity (p = .03) and diarrhoea (p = .05) than patients with income below the poverty line. After 1 month, reduction in pain intensity was observed for Nuuk citizens compared with non-Nuuk citizens (p = .05). After 2 months, non-Nuuk citizens reported improved social functioning compared with Nuuk citizens (p = .05). After 3 months, Global Health in Nuuk citizens was improved compared with non-Nuuk citizens (p = .05). An important clinical finding was that patients' needs for support are related to social status, and geographical factors should be taken into account when planning palliative care.

    Original languageEnglish
    JournalEuropean Journal of Cancer Care
    Issue number3
    Pages (from-to)e12843
    Publication statusPublished - 2018


    • Adult
    • Aged
    • Female
    • Greenland
    • Health Status
    • Humans
    • Longitudinal Studies
    • Male
    • Middle Aged
    • Neoplasms/psychology
    • Palliative Care
    • Prospective Studies
    • Quality of Life
    • Social Adjustment
    • Young Adult


    Dive into the research topics of 'Development of health-related quality of life and symptoms in patients with advanced cancer in Greenland'. Together they form a unique fingerprint.

    Cite this